Healthcare -
Biotechnology - NASDAQ - US
$ 6.99
1.16 %
$ 40.3 M
Market Cap
-0.28
P/E
ATRA - LONG-TERM DEBT
Long-term Debt ATRA - Atara Biotherapeutics, Inc.
45.7 M
LAST VALUE
33.81%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR